Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBKNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.14.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.14.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.14.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.14.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBK.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBK.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBK.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBK.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EF.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EF.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EF.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EF.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CM.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CM.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CM.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DF.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DF.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DF.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20259.7China
DF.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.35ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.35ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.35ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.35NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EH.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EH.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EH.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EH.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.3.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.3.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.3.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DF.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DF.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DF.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20259.7China
DF.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CK.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CK.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CK.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CK.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.27ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.27ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.27NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used